M.D. Anderson Cancer Center: Graft vs Host Disease trials

The registry lists 15 Graft vs Host Disease studies with M.D. Anderson Cancer Center as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 5Phase 2 9No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersRecruitingNCT06434363Phase 1/2
• Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid MyopathyTerminatedNCT04521777Not applicableResults posted
• Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
• Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)TerminatedNCT00675441Phase 2Results posted
• Photopheresis for the Treatment of Acute Graft Versus Host DiseaseCompletedNCT00609609Phase 2Results posted
• Tissue Repair in Stem Cell Transplant RecipientsTerminatedNCT00501228Not applicableResults posted
• Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantationWithdrawnNCT04127721Phase 2
• Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum AntibioticsWithdrawnNCT03862079Phase 2
• Fucosylated T Cells for Graft Versus Host Disease (GVHD) PreventionCompletedNCT02423915Phase 1
• Feasibility Study of Collecting Multicenter Chronic GVHD DataCompletedNCT00506233
• Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
• Thymoglobulin (ATG) Dose Finding StudyTerminatedNCT00409695Phase 1/2
• Experience of Having Chronic Graft-Versus-Host DiseaseCompletedNCT00353106
• Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDTerminatedNCT00038792Phase 1/2
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaCompletedNCT00002833Phase 2